Lanthanum Carbonate chewable tablets, 1000mg*
Recalled by Cipla USA, Inc.
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Cipla USA, Inc. has recalled Lanthanum Carbonate chewable tablets, 1000mg*, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on December 17, 2025 and was initiated on October 24, 2025. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Lanthanum Carbonate chewable tablets, 1000mg*, with approximately 1180 boxes affected. The company behind the recall is Cipla USA, Inc., based in Warren, NJ. The FDA describes the product as: “Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC…”
Why was Lanthanum Carbonate chewable tablets, 1000mg* recalled?
According to the FDA, the stated reason for the recall is: “Failed stability specifications: Out of specification for hardness test.”
What should you do?
If you think you may have bought Lanthanum Carbonate chewable tablets, 1000mg*, compare it against the product description and identifying codes (lot# NB240315, exp 12/31/2025) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Cipla USA, Inc. or your local health authority.
About this recall
This recall was distributed in NJ. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- December 17, 2025
- Recall started
- October 24, 2025
- Distributed in
- NJ
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Lanthanum Carbonate chewable tablets, 1000mg* recalled?+
According to the FDA: Failed stability specifications: Out of specification for hardness test
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have Lanthanum Carbonate chewable tablets, 1000mg*?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0217-2026. Information last synced from the FDA on July 6, 2026.